The use of naltrexone, an opiate antagonist, in the treatment of opiate addiction

Irish Journal of Psychological Medicine

Volumn 14, Issue 1, 1997, Pages 31-34

  Farren, Conor K ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

naltrexone; opiate addiction; opiate antagonist

Indexed keywords

METHADONE; NALTREXONE; OPIATE; OPIATE ANTAGONIST;

DRUG DEPENDENCE; HUMAN; REVIEW;

EID: 0030896687     PISSN: 07909667     EISSN: None     Source Type: Journal    
DOI: 10.1017/S0790966700002895     Document Type: Review

References (25)

1. Wilker A. Recent progress in research on the neurophysiological basis of morphine addiction. Am J Psychiatry 1948; 105: 329-38.
2. Gold MS, Pottash ALC, Sweeney DR et al. Opiate withdrawal using clonidine: a safe, effective, and rapid non-opiate treatment. J Am Medical Assoc 1980; 243: 343-6.
3. Charney DS, Riordan CE, Kleber HD. Clonidine and naltrexone: a safe, effective and rapid treatment of abrupt withdrawal from methadone therapy. Arch Gen Psychiatry 1982; 39: 1327-32.
4. Vinning E, Kosten TR, Kleber HD. Clinical utility of rapid clonidine naltrexone detoxification for opioid abusers. Br J Addictions 1988; 83: 567-75.
5. Brewer C, Rezae H, Bailey C. Opioid withdrawal and naltrexone induction in 48-72 hours with minimal drop out, using a modification of the naltrexone-clonidine technique. Br J Psychiatry 1988; 153: 340-3.
6. Loimer N, Lenz K, Schmid R, Presslich O. Technique for greatly shortening the transition from methadone to naltrexone maintenance of patients addicted to opiates. Am J Psychiatry 1991; 148: 933-5.
7. Kleber HD, Riordan CE, Rounsaville BJ. Clonidine in outpatient detoxification from methadone maintenance. Arch Gen Psychiatry 1985; 42: 391-8.
8. Kosten TR. Current pharmacotherapies for opioid dependence. Psychopharmacol Bull 1990; 26(1): 69-74.
9. Roth A, Hogan I, Farren CK. Cohesive group therapy and naltrexone for opiate abusing health professionals. J Subst Abuse Treat 1996. In Review
10. Washton AM, Pottash AC, Gold MA. Naltrexone in addicted business executives and physicians. J Clin Psychiatry 1984; 45(2): 39-41.
11. Ling W, Wesson DR. Naltrexone treatment for addicted health care professionals: a collaborative private practice experience. J Clin Psychiatry 1984; 45 (9, Sec 2): 46-8.
12. Brahen HS, Henderson RK, Capone T, Kondal N. Naltrexone treatment in a jail work release programme. J Clin Psychiatry 1984; 45(2): 49-52.
13. Anton RF, Hogan I, Jalai B, Riordan CE, Kleber HD. Multiple family therapy and naltrexone in the treatment of opiate dependence. Drug and Alcohol Dependence 1981; 8: 157-68.
14. Resnick R, Schuyten-Resnick E, Washton AM. Narcotic antagonists in the treatment of opioid dependence: review and commentary. Compr Psychiatry 1979; 20: 116-25.
15. Callahan EJ. Comparison of two naltrexone programmes: naltrexone alone versus naltrexone plus behaviour therapy. In Julius D, Renault P, eds. Narcotic antagonists: naltrexone. NIDA Research Monograph. Washington DC: Supt of Docs, US Govt Print Off 1976; 9: 150-7.
16. Callahan EJ. The tteatment of heroin addiction: naltrexone alone with behavior therapy. Am J Drug and Alcohol Abuse 1980; 7: 795-807.
17. Grabowski J. Effects of contingent payment on compliance with a naltrexone regime. Am J Drug and Alcohol Abuse 1979; 6(3): 355-65.
18. Garcia Alonzo F, Guttierez M, San L, et al. A multicenter study to introduce naltrexone for opiate dependence in Spain. Drug Alcohol Depend 1989; 23(2): 117-21.
19. Lerner A, Sigal M, Bacalu A, Shiff R, Burganski I, Gelkopf M. A naltrexone double blind placebo controlled study in Israel. Isr J Psychiatry Relat Sci 1992; 29(1): 36-43.
20. Greenstein RA, Arndt IC, McClellan AT, O'Brien CP, Evans B. Naltrexone: a clinical perspective. J Clin Psychiatry 1984; 45: 25-8.
21. Bradford HA, Hurley FL, Golondzoeske O, Dorrier C. Interim report on clinic intake and safety data collected from 17 NIDA funded naltrexone centers. In: Julius D, Renault P, eds. Narcotic antagonists: naltrexone. Rockville: NIDA Research Monogram 1975; 9: 163-71.
22. Lowinson JH, Marion IH, Joseph H, Dole VP. Methadone maintenance. In: Lowinson JH, Ruiz P, Millman RB, Langrod JG, eds. Substance abuse: a comprehensive textbook. Baltimore: Williams and Wilkins, 1992; 550-61.
23. DeLeon G, Schwartz S. The therapeutic community: what are the retention rates? Am J Drug and Alcohol Abuse 1984; 10: 267-84.
24. Higgins ST, Delaney DD, Budney AJ. A behavioral approach to achieving initial cocaine abstinence. Am J Psychiatry 1991; 148: 1218-24.
25. Hubbard R, Marsden M, Rachal J. Drug abuse treatment: a national study of effectiveness. Chapel Hill, NC: The University of North Carolina Press, 1989.